AU7163091A - Novel malarial sporozoite peptide antigens - Google Patents

Novel malarial sporozoite peptide antigens

Info

Publication number
AU7163091A
AU7163091A AU71630/91A AU7163091A AU7163091A AU 7163091 A AU7163091 A AU 7163091A AU 71630/91 A AU71630/91 A AU 71630/91A AU 7163091 A AU7163091 A AU 7163091A AU 7163091 A AU7163091 A AU 7163091A
Authority
AU
Australia
Prior art keywords
novel
peptide antigens
sporozoite
malarial
malarial sporozoite
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU71630/91A
Inventor
Michael R. Hollingdale
Barbara Sina
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BIOMEDICAL RESEARCH INSTITUTE
Original Assignee
BIOMEDICAL RES INST
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BIOMEDICAL RES INST filed Critical BIOMEDICAL RES INST
Publication of AU7163091A publication Critical patent/AU7163091A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/445—Plasmodium
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/20—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans from protozoa
    • C07K16/205—Plasmodium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
AU71630/91A 1989-12-12 1990-12-12 Novel malarial sporozoite peptide antigens Abandoned AU7163091A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US44810989A 1989-12-12 1989-12-12
US448109 1989-12-12
USNOTGIVEN 2000-11-08

Publications (1)

Publication Number Publication Date
AU7163091A true AU7163091A (en) 1991-07-18

Family

ID=23779035

Family Applications (1)

Application Number Title Priority Date Filing Date
AU71630/91A Abandoned AU7163091A (en) 1989-12-12 1990-12-12 Novel malarial sporozoite peptide antigens

Country Status (2)

Country Link
AU (1) AU7163091A (en)
WO (1) WO1991008756A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU637468B2 (en) * 1990-03-23 1993-05-27 F. Hoffmann-La Roche Ag Plasmodium sporozoite antigen

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005085288A2 (en) 2004-03-01 2005-09-15 The Cbr Institute For Biomedical Research Natural igm antibodies and inhibitors thereof
AU2014248636B2 (en) 2013-03-12 2017-03-30 Decimmune Therapeutics, Inc. Humanized anti-N2 antibodies

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4707357A (en) * 1984-06-26 1987-11-17 The United States Of America As Represented By The Secretary Of The Army Immunologically active peptides capable of inducing immunization against malaria and genes encoding therefor
CA1329124C (en) * 1987-02-02 1994-05-03 Jerald C. Sadoff Conjugate malaria vaccine

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU637468B2 (en) * 1990-03-23 1993-05-27 F. Hoffmann-La Roche Ag Plasmodium sporozoite antigen

Also Published As

Publication number Publication date
WO1991008756A1 (en) 1991-06-27

Similar Documents

Publication Publication Date Title
AU5471090A (en) Sequence synchronisation
AU2838489A (en) Live vaccine against coccidosis utilizingcoccidial sporozoites
ZA901737B (en) Peptides
AU3977589A (en) Novel peptides
AR243936A1 (en) Protein hydrolysis
GB8920357D0 (en) Peptides
AU6777490A (en) Malaria vaccine
AU7163091A (en) Novel malarial sporozoite peptide antigens
AU4661889A (en) A novel malarial sporozoite and exoerythrocytic peptide antigen
AU637468B2 (en) Plasmodium sporozoite antigen
IL90833A0 (en) Immunogenic peptide
AU3048689A (en) Immunogenic peptides
GB8905606D0 (en) Peptides
AU5450590A (en) Malaria vaccine
GB8919064D0 (en) Plasmodium merozoite rhoptries antigen
AU6563490A (en) Mechanical push-toy
AU6528790A (en) Recombinant human thrombomodulin
ZA908042B (en) Recombinant growth factors
AU6087990A (en) Psycho-pharmacological peptides
GB8907660D0 (en) Polypeptide
IE891280L (en) Recombinant antibodies
IE890703L (en) Peptides
GB8914943D0 (en) Peptides
IE893821L (en) Peptides
IE893022L (en) Peptides